Last Updated: June 17, 2026

Litigation Details for Cephalon Inc. v. InnoPharma Inc. (D. Del. 2014)


✉ Email this page to a colleague

« Back to Dashboard


Cephalon Inc. v. InnoPharma Inc. (D. Del. 2014)

Docket 1:14-cv-00590 Date Filed 2014-05-09
Court District Court, D. Delaware Date Terminated 2017-06-29
Cause 35:271 Patent Infringement Assigned To Gregory Moneta Sleet
Jury Demand None Referred To
Patents 8,609,863
Link to Docket External link to docket
Small Molecule Drugs cited in Cephalon Inc. v. InnoPharma Inc.
The small molecule drug covered by the patent cited in this case is ⤷  Start Trial .

Litigation summary and analysis for: Cephalon Inc. v. InnoPharma Inc. (D. Del. 2014)

Last updated: May 8, 2026

Cephalon Inc. v. InnoPharma Inc. (1:14-cv-00590): Litigation Summary and Patent-Themed Analysis

What case information is available for 1:14-cv-00590?

The provided case identifier is Cephalon Inc. v. InnoPharma Inc. | 1:14-cv-00590. No court docket details, asserted patents, claim charts, infringement contentions, claim constructions, procedural milestones, or final disposition are included in the input. Without those records, a complete and accurate litigation summary cannot be produced under a patent-analysis standard that requires specific dates, holdings, and patent numbers.

What litigation summary can be produced from the input?

Nothing beyond the case caption and docket number.

What patent-themed analysis can be produced from the input?

Nothing beyond the case caption and docket number. A patent-themed analysis requires at least: the asserted patent set, the product/drug at issue, filing posture (e.g., ANDA, counterclaim posture), claim construction outcomes, infringement theories, validity/unenforceability grounds, and the final outcome (dismissal, settlement, judgment, or consent decree). None of those elements are present.

What is actionable right now for business decisions?

No actionable litigation facts can be extracted from the input alone, so no defensible assessment of:

  • infringement risk by product and mechanism,
  • invalidity likelihood based on claim construction,
  • licensing or settlement leverage,
  • remaining enforceability exposure,
  • or design-around guidance can be produced.

Key Takeaways

  • No litigation facts are present in the provided input beyond the case caption and docket number.
  • A complete, accurate litigation summary and patent analysis cannot be generated without asserted patents, key rulings, and outcome.

FAQs

1) What patents were asserted in Cephalon Inc. v. InnoPharma Inc. (1:14-cv-00590)?

Not provided in the input.

2) What drug or product is at issue in 1:14-cv-00590?

Not provided in the input.

3) What did the court decide on claim construction or dispositive motions?

Not provided in the input.

4) Did the case end in a judgment, dismissal, or settlement?

Not provided in the input.

5) Where can I find the official filings for 1:14-cv-00590?

Not provided in the input.


References

[1] Cephalon Inc. v. InnoPharma Inc., 1:14-cv-00590 (case identifier provided in prompt).

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.